Phibro Animal Health Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
For the six months, sales was USD 481.29 million compared to USD 477.17 million a year ago. Net loss was USD 6.74 million compared to net income of USD 11.07 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to basic earnings per share from continuing operations of USD 0.27 a year ago. Diluted loss per share from continuing operations was USD 0.17 compared to diluted earnings per share from continuing operations of USD 0.27 a year ago.